Breaking News Headlines Today

News from lifesciencesbc.ca

Stay current with all the latest and breaking news from lifesciencesbc.ca. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 55 of lifesciencesbc.ca’s headlines and news stories over the past 3 months.

Ground News rates lifesciencesbc.ca’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

lifesciencesbc.ca’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about lifesciencesbc.ca

Where is lifesciencesbc.ca located?lifesciencesbc.ca's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top lifesciencesbc.ca News

David Eby · British Columbia

B.C. Premier David Eby reshuffles cabinet to boost economy and jobs

71% Left coverage: 28 sources

See the Story

British Columbia · British Columbia

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore ...

100% Left coverage: 1 sources

VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation platform designed to restore innate immune function, is excited to report that they have completed…See the Story

West Palm Beach · West Palm Beach

‘On the Record’: Combating Cystic Fibrosis

100% Center coverage: 1 sources

A diagnosis led to a father going on a mission to fight cystic fibrosis. WPBF 25 goes “On the Record” with several South Florida organizations about their fight against the disease.See the Story

FDA Grants Priority Review to TAR-200 in BCG-Unresponsive High-Risk NMIBC

Phase 2b SunRISe-1 trial findings supported the FDA to grant priority review to TAR-200 in BCG-unresponsive high-risk NMIBC with carcinoma in situ.United States · United States See the Story

Simon Fraser University - SFU Teams up with Fraser Health to Launch New Health Research Institute

Simon Fraser University is partnering with Fraser Health to launch a new health research institute aimed at tackling some of the most pressing health issues across the region.The SFU-FH Health. . .Education · British Columbia See the Story

AstraZeneca Canada and Plan International Canada Announce 10 Young Visionaries Named to the 2025-2026 Eureka Fellowship for Youth Changemakers in Canada - Life Sciences British Columbia

New class of Eureka Fellows selected for their outstanding efforts to build a healthier, more equitable world and will receive support to amplify their sustainability impact in Canada and around […]British Columbia · British Columbia Read Article

Bio-economy employers to have access to new practical training to address workplace harassment - Life Sciences British Columbia

OTTAWA, July 10, 2025 – Employers in Canada’s bio-economy will gain support with a new initiative addressing workplace sexual harassment. BioTalent Canada’s latest project, Building a safer bio-economy: Addressing sexual harassment in […]Vancouver, British Columbia · Vancouver Read Article

AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma

57% Center coverage: 7 sources

AbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile.AbbVie See the Story

Getinge and Zimmer Biomet announce strategic partnership in the ASC sector – Ortho Spine News

GOTHENBURG, SWEDEN AND WARSAW, IND. – July 10, 2025 – Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), today announced a strategic partnership where Zimmer Biomet will distribute Getinge’s Operating Room (OR) capital products to its Ambulatory Surgery Center (ASC) customers. This partnership creates a turnkey solution for ASC customers, who can now access Getinge’s infection control and surgical portfolio andBritish Columbia · British Columbia See the Story

Labcorp and NOWDx Collaborate to Expand Access to Rapid Syphilis Testing - Life Sciences British Columbia

Labcorp, a leader of laboratory services, announced a new initiative with NOWDiagnostics to expand access to rapid syphilis testing.Victoria, British Columbia · Victoria Read Article

Acuitas Therapeutics and Researchers at the University of Pennsylvania Demonstrate Enhanced T Cell Immunity with IL-12 mRNA-LNP Adjuvant - Life Sciences British Columbia

Acuitas announced the publication of new study, “An IL12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses.”Vancouver, British Columbia · Vancouver Read Article

News from lifesciencesbc.ca

News from lifesciencesbc.ca

Information about lifesciencesbc.ca

Media Bias Ratings

Factuality

Ownership

Top lifesciencesbc.ca News

B.C. Premier David Eby reshuffles cabinet to boost economy and jobs

Qu Biologics Completes Enrolment of a Unique Study Testing a Novel Immunomodulator to Restore ...

‘On the Record’: Combating Cystic Fibrosis

FDA Grants Priority Review to TAR-200 in BCG-Unresponsive High-Risk NMIBC

Simon Fraser University - SFU Teams up with Fraser Health to Launch New Health Research Institute

AstraZeneca Canada and Plan International Canada Announce 10 Young Visionaries Named to the 2025-2026 Eureka Fellowship for Youth Changemakers in Canada - Life Sciences British Columbia

Bio-economy employers to have access to new practical training to address workplace harassment - Life Sciences British Columbia

AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma

Getinge and Zimmer Biomet announce strategic partnership in the ASC sector – Ortho Spine News

Labcorp and NOWDx Collaborate to Expand Access to Rapid Syphilis Testing - Life Sciences British Columbia

Acuitas Therapeutics and Researchers at the University of Pennsylvania Demonstrate Enhanced T Cell Immunity with IL-12 mRNA-LNP Adjuvant - Life Sciences British Columbia

Similar News Topics

Topics Most Covered by lifesciencesbc.ca

Sources Covering Similar Topics

Breaking News Topics Related to lifesciencesbc.ca

Information about lifesciencesbc.ca

Media Bias Ratings

Factuality

Ownership

FDA Grants Priority Review to TAR-200 in BCG-Unresponsive High-Risk NMIBC

Simon Fraser University - SFU Teams up with Fraser Health to Launch New Health Research Institute

AstraZeneca Canada and Plan International Canada Announce 10 Young Visionaries Named to the 2025-2026 Eureka Fellowship for Youth Changemakers in Canada - Life Sciences British Columbia

Bio-economy employers to have access to new practical training to address workplace harassment - Life Sciences British Columbia

AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma

Getinge and Zimmer Biomet announce strategic partnership in the ASC sector – Ortho Spine News

Labcorp and NOWDx Collaborate to Expand Access to Rapid Syphilis Testing - Life Sciences British Columbia

Acuitas Therapeutics and Researchers at the University of Pennsylvania Demonstrate Enhanced T Cell Immunity with IL-12 mRNA-LNP Adjuvant - Life Sciences British Columbia